Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)
Clinical trial NCT00379613 · COMPLETED
Trial details
- NCT number
- NCT00379613
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-07
- Primary completion
- 2004-07-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.